Imugene LtdASX: IMU

AGM Presentation

· Issued by Imugene Ltd via ASX

Filed with ASX · · 3 pages · English

Release

What Has Been Achieved To Date? AGM2026 COMBINATION DOSING BTK inhibitors are a ~US$12bn global market (2025). STRATEGY FOR BTKI FAILURES 140 Oral presentations at ASH 2025 and ASCO 2026,as well as PEER RECOGNITION Total patients treated with azer-cel in selection for a Poster presentation at ASH...

Imugene Ltd on 6ix

Earlier from Imugene

Later from Imugene

All Imugene news releases